reference/34995041

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34995041

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2162-402X
issueIdentifier	1
pageRange	2118210-
publicationName	OncoImmunology
startingPage	2118210
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7ae88100ecf50b03d1a9926d6373cde2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0897b619170e9194b13895681e410f62 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Li X, Lu M, Yuan M, Ye J, Zhang W, Xu L, Wu X, Hui B, Yang Y, Wei B, Guo C, Wei M, Dong J, Wu X, Gu Y. CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy. OncoImmunology. 2022 Aug 31;11(1). doi: 10.1080/2162402x.2022.2118210.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c71b481e591c9fbf62adf5dded90b405 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e18b869e6e17855a98ca787d8e87ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64ed77f8c5e5df5f3a113781bf872d51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_108403bcdad3b4b1d1e09d4360574641 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84df2ae48aa349db7c82d8c3c479f082 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53355d1fc681268781a351bc3ac6916b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e80102ed706f1be38ee3c11e775fb850 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9596459788a328663d59736eca1bbdae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b0d3bea5ce549b31abbbe709a041681 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1757f2482e642539f7e56595a94b8300 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75e3fd914f3e23158e1db2087f618d3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0eff99d9e77db324961ba30647a70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c53db87596be871f4e0a7eef4ef816b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac472beea28237c888f21dc3f61cf2db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43765de6f1cfb64d897431d960a9780a
date	2022-08-31^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1080/2162402x.2022.2118210 https://pubmed.ncbi.nlm.nih.gov/PMC9450898 https://pubmed.ncbi.nlm.nih.gov/36092638
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39616 https://portal.issn.org/resource/ISSN/2162-402X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy
discusses	http://id.nlm.nih.gov/mesh/M0148772 http://id.nlm.nih.gov/mesh/M0295804
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D050504Q000235 http://id.nlm.nih.gov/mesh/D018232 http://id.nlm.nih.gov/mesh/D000257 http://id.nlm.nih.gov/mesh/D009369Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D054357Q000235 http://id.nlm.nih.gov/mesh/D002633 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000256Q000235 http://id.nlm.nih.gov/mesh/D059016
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e50e73958d425602fc87154ff45fae79 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b387b380494e5b0a9f1326bde8659036 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5c647247cf24a968b74ef2791c1bfa48 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aba283fcf2192afdf79c2b7da206ab70 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5b23d551e5b951bd68416ea80d54d341

Showing number of triples: 1 to 55 of 55.